As Betsy wrote above, all patients have completed the course of drugs in the Georgetown trial and the data is being analyzed. The open-phase post-trial is now ongoing where all volunteers are receiving the drug. Some blood/PK data has been analyzed with initial results already released.

The Northwestern U. trial (referred by some as the MJFF trial) is still ongoing. All volunteers have been recruited and about 1/3 have already completed. All will be completed by July. I would anticipate data released sometime near year-end. Decisions for funding a Phase 3 will be dependent on the results of the Phase 2 safety/dosing trial.